Bone marrow graft-versus-host disease: Evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 4, 2014, Pages 495-500

  Shono, Yusuke ^a,f   Shiratori, Souichi ^a   Kosugi Kanaya, Mizuha ^a   Ueha, Satoshi ^b   Sugita, Junichi ^a   Shigematsu, Akio ^a   Kondo, Takeshi ^a   Hashimoto, Daigo ^a   Fujimoto, Katsuya ^a   Endo, Tomoyuki ^a   Nishio, Mitsufumi ^a   Hashino, Satoshi ^a   Matsuno, Yoshihiro ^c   Matsushima, Kouji ^b   Tanaka, Junji ^d   Imamura, Masahiro ^e   Teshima, Takanori ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SAPPORO HOKUYU HOSPITAL   (Japan)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bone marrow graft versus host disease (BM GVHD); Idiopathic cytopenias; Osteoblasts

Indexed keywords

CD19 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; CYTOMETRY; CYTOPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOBLASTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; OSTEOBLAST; T CELL LEUKEMIA; T LYMPHOCYTE; YOUNG ADULT;

BONE MARROW GRAFT-VERSUS-HOST DISEASE (BM GVHD); IDIOPATHIC CYTOPENIAS; OSTEOBLASTS;

ADULT; AGED; ANTIGENS, CD19; B-LYMPHOCYTES; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84895830773     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.12.568     Document Type: Article

References (22)

1. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
2. Abrahamsen I.W., Somme S., Heldal D., et al. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005, 90:86-93.
3. Crooks G.M., Weinberg K., Mackall C. Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant 2006, 12:42-46.
4. Imamura M. Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantation. Int J Hematol 2002, 76(Suppl 1):191-194.
5. Peggs K.S. Immune reconstitution following stem cell transplantation. Leuk Lymphoma 2004, 45:1093-1101.
6. Baker M.B., Riley R.L., Podack E.R., Levy R.B. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc Natl Acad Sci U S A 1997, 94:1366-1371.
7. Iwasaki T., Hamano T., Saheki K., et al. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells. Cell Immunol 1999, 197:30-38.
8. Mori T., Nishimura T., Ikeda Y., et al. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression. Blood 1998, 92:101-107.
9. Shono Y., Ueha S., Wang Y., et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010, 115:5401-5411.
10. Flowers M.E., Kansu E., Sullivan K.M. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clinics North Am 1999, 13:1091-1112.
11. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
12. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
13. Ely S.A., Knowles D.M. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol 2002, 160:1293-1299.
14. Kanda Y. Investigation of the freely available easy-to-use software 'EZR'for medical statistics. Bone Marrow Transplant 2013, 48:452-458.
15. Tauchmanova L., Colao A., Lombardi G., et al. Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. JClin Endocrinol Metab 2007, 92:4536-4545.
16. Falzarano G., Krenger W., Snyder K.M., et al. Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease. Blood 1996, 87:2853-2860.
17. Garvy B.A., Elia J.M., Hamilton B.L., Riley R.L. Suppression of B-cell development as a result of selective expansion of donor T cells during the minor H antigen graft-versus-host reaction. Blood 1993, 82:2758-2766.
18. Storek J., Wells D., Dawson M.A., et al. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001, 98:489-491.
19. Xenocostas A., Osmond D.G., Lapp W.S. The effect of the graft-versus-host reaction on B lymphocyte production in bone marrow of mice. Depressed genesis of early progenitors prior to mu heavy chain expression. Transplantation 1991, 51:1089-1096.
20. Fedoriw Y., Samulski T.D., Deal A.M., et al. Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development. Biol Blood Marrow Transplant 2012, 18:968-973.
21. Shima T., Miyamoto T., Kikushige Y., et al. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. Blood 2013, 121:840-848.
22. Pereira R.M., Delany A.M., Canalis E. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone 2001, 28:484-490.